Reuters: Weight-loss drugs may reduce alcohol cravings

Weight-loss drugs may affect alcohol consumption: Reuters

Weight-loss drugs based on GLP-1 agonists may alter people's consumer behaviour, including affecting their desire to consume alcohol. This is reported by Reuters.

Such drugs, including Wegovy and Ozempic, are used to treat obesity and diabetes. Against the backdrop of the widespread use of these medications, alcohol producers are monitoring potential changes in consumer habits.

According to Reuters, some people taking GLP-1 drugs report a decrease in cravings for alcohol. Researchers are also studying the possible link between the action of these drugs and changes in alcohol consumption.

Changes in consumer behaviour may be significant for the beer industry if the trend towards reduced alcohol consumption becomes more widespread.

At Heineken, according to Reuters, changes in the operations of food service establishments are being considered. Bars, in particular, are advised to offer customers more non-alcoholic beverages and to reduce the size of food portions.

Meanwhile, GLP-1 drugs are primarily intended for medical use, and their impact on alcohol consumption remains a subject of scientific research. The reduction in alcohol cravings reported by individual patients does not imply the same reaction in all people.